283 related articles for article (PubMed ID: 30058421)
1. Pravastatin polarizes the phenotype of macrophages toward M2 and elevates serum cholesterol levels in apolipoprotein E knockout mice.
Zhang X; Xiao S; Li Q
J Int Med Res; 2018 Aug; 46(8):3365-3373. PubMed ID: 30058421
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice.
Park KY; Heo TH
Cardiovasc Ther; 2018 Dec; 36(6):e12476. PubMed ID: 30378752
[TBL] [Abstract][Full Text] [Related]
3. The Anti-Atherosclerotic Effects of Buyang Huanwu Decoction through M1 and M2 Macrophage Polarization in an ApoE Knockout Mouse Model.
Ji M; Mao L; Wei Y; Zhu B; Zhai Y; Zhou X; Tao W; Wang W; Wu H
J Physiol Investig; 2024 Mar; 67(2):79-87. PubMed ID: 38780292
[TBL] [Abstract][Full Text] [Related]
4. Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.
Harada N; Ito K; Hosoya T; Mimura J; Maruyama A; Noguchi N; Yagami K; Morito N; Takahashi S; Maher JM; Yamamoto M; Itoh K
Free Radic Biol Med; 2012 Dec; 53(12):2256-62. PubMed ID: 23051009
[TBL] [Abstract][Full Text] [Related]
5. Pravastatin attenuates atherosclerosis after myocardial infarction by inhibiting inflammatory Ly6C
Chen Y; Zhang H; Hu L; Shi H; Liu X; Jia J; Sun S; Ou Y; Luo X; Zhou G; Shen W
J Int Med Res; 2020 Jul; 48(7):300060520932816. PubMed ID: 32662710
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function.
Mehta NU; Grijalva V; Hama S; Wagner A; Navab M; Fogelman AM; Reddy ST
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1152-63. PubMed ID: 27079878
[TBL] [Abstract][Full Text] [Related]
7. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
8. Anti-atherosclerotic effects of pravastatin in brachiocephalic artery in comparison with en face aorta and aortic roots in ApoE/LDLR
Kostogrys RB; Franczyk-Zarow M; Gasior-Glogowska M; Kus E; Jasztal A; Wrobel TP; Baranska M; Czyzynska-Cichon I; Drahun A; Manterys A; Chlopicki S
Pharmacol Rep; 2017 Feb; 69(1):112-118. PubMed ID: 27915184
[TBL] [Abstract][Full Text] [Related]
9. Inflammation contributes to the atherogenic role of intermittent hypoxia in apolipoprotein-E knock out mice.
Arnaud C; Poulain L; Lévy P; Dematteis M
Atherosclerosis; 2011 Dec; 219(2):425-31. PubMed ID: 21917260
[TBL] [Abstract][Full Text] [Related]
10. Crude α-Mangostin Suppresses the Development of Atherosclerotic Lesions in
Shibata MA; Harada-Shiba M; Shibata E; Tosa H; Matoba Y; Hamaoka H; Iinuma M; Kondo Y
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959963
[TBL] [Abstract][Full Text] [Related]
11. Pravastatin attenuates interferon-gamma action via modulation of STAT1 to prevent aortic atherosclerosis in apolipoprotein E-knockout mice.
Zhou XX; Gao PJ; Sun BG
Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):373-9. PubMed ID: 19018808
[TBL] [Abstract][Full Text] [Related]
12. Aged Garlic Extract Suppresses the Development of Atherosclerosis in Apolipoprotein E-Knockout Mice.
Morihara N; Hino A; Yamaguchi T; Suzuki J
J Nutr; 2016 Feb; 146(2):460S-463S. PubMed ID: 26764329
[TBL] [Abstract][Full Text] [Related]
13. Pravastatin improves atherosclerosis in mice with hyperlipidemia by inhibiting TREM-1/DAP12.
Wang HM; Gao JH; Lu JL
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4995-5003. PubMed ID: 30070336
[TBL] [Abstract][Full Text] [Related]
14. Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice.
Yin M; Liu Q; Yu L; Yang Y; Lu M; Wang H; Luo D; Rong X; Tang F; Guo J
J Vasc Res; 2017; 54(3):123-130. PubMed ID: 28448973
[TBL] [Abstract][Full Text] [Related]
15. G004, a synthetic sulfonylurea compound, exerts anti-atherosclerosis effects by targeting SIRT1 in ApoE
Qian L; Ma L; Wu G; Yu Q; Lin H; Ying Q; Wen D; Gao C
Vascul Pharmacol; 2017 Feb; 89():49-57. PubMed ID: 28069546
[TBL] [Abstract][Full Text] [Related]
16. Effects of atorvastatin and/or probucol on recovery of atherosclerosis in high-fat-diet-fed apolipoprotein E-deficient mice.
Guo X; Wang L; Xia X; Wang P; Li X
Biomed Pharmacother; 2019 Jan; 109():1445-1453. PubMed ID: 30551396
[TBL] [Abstract][Full Text] [Related]
17. Probucol-Oxidized Products, Spiroquinone and Diphenoquinone, Promote Reverse Cholesterol Transport in Mice.
Yakushiji E; Ayaori M; Nishida T; Shiotani K; Takiguchi S; Nakaya K; Uto-Kondo H; Ogura M; Sasaki M; Yogo M; Komatsu T; Lu R; Yokoyama S; Ikewaki K
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):591-7. PubMed ID: 26848156
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol-lowering independent regression and stabilization of atherosclerotic lesions by pravastatin and by antimonocyte chemoattractant protein-1 therapy in nonhuman primates.
Kitamoto S; Nakano K; Hirouchi Y; Kohjimoto Y; Kitajima S; Usui M; Inoue S; Egashira K
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1522-8. PubMed ID: 15178560
[TBL] [Abstract][Full Text] [Related]
19. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
[TBL] [Abstract][Full Text] [Related]
20. Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice.
Shah PK; Nilsson J; Kaul S; Fishbein MC; Ageland H; Hamsten A; Johansson J; Karpe F; Cercek B
Circulation; 1998 Mar; 97(8):780-5. PubMed ID: 9498542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
